SARS-CoV-2 Reinfection Risk in Persons with HIV, Chicago, Illinois, USA, 2020-2022

被引：3

作者：

Teran, Richard A. ^{[1
,2
,3
]}

Gagner, Alexandra ^{[2
]}

Gretsch, Stephanie ^{[2
]}

Lauritsen, Jeff ^{[2
]}

Galanto, Daniel ^{[2
]}

Walblay, Kelly ^{[2
]}

Ruestow, Peter ^{[2
]}

Korban, Colin ^{[2
]}

Pacilli, Massimo ^{[2
]}

Kern, David ^{[2
]}

Black, Stephanie R. ^{[2
]}

Tabidze, Irina ^{[2
]}

机构：

[1] Ctr Dis Control & Prevent, 1600 Clifton Rd NE,Mailstop H21-10, Atlanta, GA 30329 USA

[2] Chicago Dept Publ Hlth, Chicago, IL USA

[3] CDCP, 1600 Clifton Rd NE Mailstop H24-4, Atlanta, GA 30329 USA

来源：

EMERGING INFECTIOUS DISEASES | 2023年 / 29卷 / 11期

关键词：

CORONAVIRUS DISEASE 2019; UNITED-STATES; COVID-19; VACCINATION; INFECTION; ADULTS; HOSPITALIZATION; INDIVIDUALS; ILLNESS; RATES;

D O I：

10.3201/eid2911.230577

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Understanding if persons with HIV (PWH) have a higher risk for SARS-CoV-2 reinfection may help tailor future COVID-19 public health guidance. To determine whether HIV infection was associated with increased risk for SARS-CoV-2 reinfection, we followed adult longitudinally from their first reported infection through May 31, 2022. We matched SARS-CoV-2 laboratory data and COVID-19 vaccine administration data to Chicago's Enhanced HIV/AIDS Reporting System. Among 453,587 Chicago residents with SARS-CoV-2, a total of 5% experienced a SARS-CoV-2 reinfection, including 192/2,886 (7%) PWH and 23,642/450,701 (5%) persons without HIV. We observed higher SARS-CoV-2 reinfection incidence rates among PWH (66 [95% CI 57-77] cases/1,000 person-years) than PWOH (50 [95% CI adjusted rate of SARS-CoV-2 reinfection (1.46, 95% CI 1.27-1.68) than those without HIV. PWH should follow the recommended COVID-19 vaccine schedule, including booster doses.

引用

页码：2257 / 2265

页数：9

共 50 条

[31] Community Transmission of SARS-CoV-2 at Two Family Gatherings - Chicago, Illinois, February-March 2020
Ghinai, Isaac
Woods, Susan
Ritger, Kathleen A.
McPherson, Tristan D.
Black, Stephanie R.
Sparrow, Laura
Fricchione, Marielle J.
Kerins, Janna L.
Pacilli, Massimo
Ruestow, Peter S.
Arwady, M. Allison
Beavers, Suzanne F.
Payne, Daniel C.
Kirking, Hannah L.
Layden, Jennifer E.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2020, 69 (15): : 446 - 450
[32] Pediatric SARS-CoV-2 Seroprevalence, Oregon, USA, November 2020-June 2022
Falender, Rebecca A.
Mitchell, Paul G.
Guzman-Cottrill, Judith A.
Cieslak, Paul R.
Sutton, Melissa
EMERGING INFECTIOUS DISEASES, 2023, 29 (08) : 1672 - 1675
[33] Assessment of Hospital-Onset SARS-CoV-2 Infection Rates and Testing Practices in the US, 2020-2022
Hatfield, Kelly M.
Baggs, James
Maillis, Alexander
Warner, Sarah
Jernigan, John A.
Kadri, Sameer S.
Klompas, Michael
Reddy, Sujan C.
JAMA NETWORK OPEN, 2023, 6 (08) : e2329441
[34] Association of Culturable-Virus Detection and Household Transmission of SARS-CoV-2, California and Tennessee, 2020-2022
Deyoe, Jessica E.
Kelly, J. Daniel
Grijalva, Carlos G.
Bonenfant, Gaston
Lu, Scott
Anglin, Khamal
Garcia-Knight, Miguel
Pineda-Ramirez, Jesus
Hagen, Melissa Briggs
Saydah, Sharon
Abedi, Glen R.
Goldberg, Sarah A.
Tassetto, Michel
Zhang, Amethyst
Donohue, Kevin C.
Davidson, Michelle C.
Sanchez, Ruth Diaz
Djomaleu, Manuella
Mathur, Sujata
Shak, Joshua R.
Deeks, Steven G.
Peluso, Michael J.
Chiu, Charles Y.
Zhu, Yuwei
Halasa, Natasha B.
Chappell, James D.
Mellis, Alexandra
Reed, Carrie
Andino, Raul
Martin, Jeffrey N.
Zhou, Bin
Talbot, H. Keipp
Midgley, Claire M.
Rolfes, Melissa A.
JOURNAL OF INFECTIOUS DISEASES, 2023, 227 (12): : 1343 - 1347
[35] The increase in SARS-CoV-2 lineages during 2020-2022 in a state in the Brazilian Northeast is associated with a number of cases
Freitas, Moises Thiago de Souza
Sena, Ludmila Oliveira Carvalho
Fukutani, Kiyoshi Ferreira
dos Santos, Cliomar Alves
Barros Neto, Francisco das Chagas
Ribeiro, Julienne Sousa
dos Reis, Erica Santos
Balbino, Valdir de Queiroz
Leitao, Sergio de Sa Paiva
Batista, Marcus Vinicius de Aragao
Lipscomb, Michael Wheeler
de Moura, Tatiana Rodrigues
FRONTIERS IN PUBLIC HEALTH, 2023, 11
[36] Changes in the Incidence of Invasive Pneumococcal Disease in Calgary, Canada, during the SARS-CoV-2 Pandemic 2020-2022
Ricketson, Leah J. J.
Kellner, James D. D.
MICROORGANISMS, 2023, 11 (05)
[37] Symptom severity in an outbreak of SARS-CoV-2 at a university student gala in the Omicron era, Chicago, Illinois, April 2022
Vaughn, Jocelyn
Karayeva, Evgenia
Lopez-Yanez, Natalia
Hershow, Ronald C.
JOURNAL OF AMERICAN COLLEGE HEALTH, 2025, 73 (01) : 41 - 45
[38] Risk Factors Contributing to Reinfection by SARS-CoV-2: A Systematic Review
Gomez-Gonzales, Walter
Chihuantito-Abal, Luis A.
Gamarra-Bustillos, Carlos
Moron-Valenzuela, Julia
Zavaleta-Oliver, Jenny
Gomez-Livias, Maria
Vargas-Pancorbo, Lidia
Auqui-Canchari, Maria E.
Mejia-Zambrano, Henry
ADVANCES IN RESPIRATORY MEDICINE, 2023, 91 (06) : 560 - 570
[39] Reinfection With SARS-CoV-2: Implications for Vaccines
Cohen, Jeffrey, I
Burbelo, Peter D.
CLINICAL INFECTIOUS DISEASES, 2021, 73 (11) : E4223 - E4228
[40] A case of SARS-CoV-2 reinfection in Ecuador
Prado-Vivar, Belen
Becerra-Wong, Monica
Guadalupe, Juan Jose
Marquez, Sully
Gutierrez, Bernardo
Rojas-Silva, Patricio
Grunauer, Michelle
Trueba, Gabriel
Barragan, Veronica
Cardenas, Paul
LANCET INFECTIOUS DISEASES, 2020, 21 (06): : E142 - E142

← 1 2 3 4 5 →